The rapid rise of GLP-1 therapies is driving a profound shift in how consumers approach food, redefining not only eating habits but also the very concept of nutritional value.
The move represents a significant step in the company’s international commercialization strategy, as it looks to position PEKILO as a viable, sustainable protein ingredient for food manufacturers across the United States.
This innovative product represents the powdered evolution of the company’s iconic Tiger Paste, specifically engineered to provide bakers and industrial food manufacturers with a more versatile, ready-to-use solution for creating the popular “tiger” or “crackle” crust on savory baked goods.
The ingredient positions itself as a compelling alternative to conventional synthetic vanillin, which has long struggled to meet the growing consumer demand for recognizable, natural ingredients on product labels.
The findings highlight the company’s commitment to sustainability and ingredient innovation in the global bakery sector.